Literature DB >> 33020143

Allosterically Potentiated α7 Nicotinic Acetylcholine Receptors: Reduced Calcium Permeability and Current-Independent Control of Intracellular Calcium.

Douglas R Miller1, Habibeh Khoshbouei1, Sumanta Garai1, Lucas N Cantwell1, Clare Stokes1, Ganesh Thakur1, Roger L Papke2.   

Abstract

The currents of α7 nicotinic acetylcholine receptors activated by acetylcholine (ACh) are brief. The channel has high permeability to calcium relative to monovalent cations and shows inward rectification. It has been previously noted that in the presence of positive allosteric modulators (PAMs), currents through the channels of α7 receptors differ from normal α7 currents both in sensitivity to specific channel blockers and their current-voltage (I-V) relationships, no longer showing inward rectification. Linear I-V functions are often associated with channels lacking calcium permeability, so we measured the I-V functions of α7 receptors activated by ACh when PAMs were bound to the allosteric binding site in the transmembrane domain. Currents were recorded in chloride-free Ringer's solution with low or high concentrations of extracellular calcium to determine the magnitude of the reversal potential shift in the two conditions as well as the I-V relationships. ACh-evoked currents potentiated by the allosteric agonist-PAMs (ago-PAMs) (3aR,4S,9bS)-4-(4-bromophenyl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-8-sulfonamide (GAT107) and 3-(3,4-difluorophenyl)-N-(1-(6-(4-(pyridin-2-yl)piperazin-1-yl)pyrazin-2-yl)ethyl)propenamide (B-973B) showed reduced inward rectification and calcium-dependent reversal potential shifts decreased by 80%, and 50%, respectively, compared with currents activated by ACh alone, indicative of reduced calcium permeability. Currents potentiated by 3a,4,5,9b-tetrahydro-4-(1-naphthalenyl)-3H-cyclopentan[c]quinoline-8-sulfonamide were also linear and showed no calcium-dependent reversal potential shifts. The ago-PAMs GAT-107 and B-973B stimulated increases in intracellular calcium in stably transfected HEK293 cells. However, these calcium signals were delayed relative to channel activation produced by these agents and were insensitive to the channel blocker mecamylamine. Our results indicate that, although allosterically activated α7 nicotinic ACh receptor may affect intracellular calcium levels, such effects are not likely due to large channel-dependent calcium influx. SIGNIFICANCE STATEMENT: Positive allosteric modulators (PAMs) of α7 nicotinic acetylcholine receptor can increase channel activation by two or more orders of magnitude, raising the concern that, due to the relatively high calcium permeability of α7 receptors activated by acetylcholine alone, such efficacious PAMs may have cytotoxic side effects. We show that PAMs alter the ion conduction pathway and, in general, reduce the calcium permeability of the channels. This supports the hypothesis that α7 effects on intracellular calcium may be independent of channel-mediated calcium influx.
Copyright © 2020 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33020143      PMCID: PMC7662531          DOI: 10.1124/molpharm.120.000012

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  62 in total

1.  Fractional Ca(2+) current through human neuronal alpha7 nicotinic acetylcholine receptors.

Authors:  Sergio Fucile; Massimiliano Renzi; Pedro Lax; Fabrizio Eusebi
Journal:  Cell Calcium       Date:  2003-08       Impact factor: 6.817

2.  Critical Molecular Determinants of α7 Nicotinic Acetylcholine Receptor Allosteric Activation: SEPARATION OF DIRECT ALLOSTERIC ACTIVATION AND POSITIVE ALLOSTERIC MODULATION.

Authors:  Nicole A Horenstein; Roger L Papke; Abhijit R Kulkarni; Ganesh U Chaturbhuj; Clare Stokes; Khan Manther; Ganesh A Thakur
Journal:  J Biol Chem       Date:  2016-01-07       Impact factor: 5.157

3.  A mutation in the extracellular domain of the α7 nAChR reduces calcium permeability.

Authors:  José O Colón-Sáez; Jerrel L Yakel
Journal:  Pflugers Arch       Date:  2013-11-01       Impact factor: 3.657

4.  Investigation of the molecular mechanism of the α7 nicotinic acetylcholine receptor positive allosteric modulator PNU-120596 provides evidence for two distinct desensitized states.

Authors:  Dustin K Williams; Jingyi Wang; Roger L Papke
Journal:  Mol Pharmacol       Date:  2011-09-01       Impact factor: 4.436

5.  Adjusting for multiple testing when reporting research results: the Bonferroni vs Holm methods.

Authors:  M Aickin; H Gensler
Journal:  Am J Public Health       Date:  1996-05       Impact factor: 9.308

6.  Neuronal nicotinic acetylcholine receptors are blocked by intracellular spermine in a voltage-dependent manner.

Authors:  A P Haghighi; E Cooper
Journal:  J Neurosci       Date:  1998-06-01       Impact factor: 6.167

7.  NACHO Mediates Nicotinic Acetylcholine Receptor Function throughout the Brain.

Authors:  Jose A Matta; Shenyan Gu; Weston B Davini; Brian Lord; Edward R Siuda; Anthony W Harrington; David S Bredt
Journal:  Cell Rep       Date:  2017-04-25       Impact factor: 9.423

8.  alpha 5 Subunit alters desensitization, pharmacology, Ca++ permeability and Ca++ modulation of human neuronal alpha 3 nicotinic receptors.

Authors:  V Gerzanich; F Wang; A Kuryatov; J Lindstrom
Journal:  J Pharmacol Exp Ther       Date:  1998-07       Impact factor: 4.030

9.  Voltage- and Temperature-Dependent Allosteric Modulation of α7 Nicotinic Receptors by PNU120596.

Authors:  Fabrio Sitzia; Jon T Brown; Andrew D Randall; John Dunlop
Journal:  Front Pharmacol       Date:  2011-12-27       Impact factor: 5.810

10.  Methamphetamine regulation of activity and topology of ventral midbrain networks.

Authors:  Douglas R Miller; Joseph J Lebowitz; Dylan T Guenther; Alexander J Refowich; Carissa Hansen; Andrew P Maurer; Habibeh Khoshbouei
Journal:  PLoS One       Date:  2019-09-19       Impact factor: 3.240

View more
  2 in total

1.  Stable desensitization of α7 nicotinic acetylcholine receptors by NS6740 requires interaction with S36 in the orthosteric agonist binding site.

Authors:  Maria Chiara Pismataro; Nicole A Horenstein; Clare Stokes; Clelia Dallanoce; Ganesh A Thakur; Roger L Papke
Journal:  Eur J Pharmacol       Date:  2021-05-15       Impact factor: 5.195

Review 2.  Therapeutic Targeting of α7 Nicotinic Acetylcholine Receptors.

Authors:  Roger L Papke; Nicole A Horenstein
Journal:  Pharmacol Rev       Date:  2021-07       Impact factor: 18.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.